Malfertheiner, P. et al. Helicobacter pylori infection. Nat. Rev. Dis. Primers. 9, 19 (2023).
Chen, Y. C. et al. Global prevalence of Helicobacter pylori infection and incidence of gastric cancer between 1980 and 2022. Gastroenterology 166, 605–619 (2024).
Denic, M., Touati, E., De Reuse, H. & Review Pathogenesis of Helicobacter pylori infection. Helicobacter 25 (Suppl 1), e12736 (2020).
Malfertheiner, P. et al. Management of Helicobacter pylori infection-the Maastricht V/Florence consensus report. Gut 66, 6–30 (2017).
Kuo, C. H., Chen, Y. H., Goh, K. L. & Chang, L. L. Helicobacter pylori and systemic disease. Gastroenterol. Res. Pract. 358494 (2014).
Chen, C. C. et al. The interplay between Helicobacter pylori and Gastrointestinal microbiota. Gut Microbes. 13, 1–22 (2021).
Wang, F. et al. Research progress on Helicobacter pylori infection related neurological diseases. Ageing Res. Rev. 99, 102399 (2024).
He, J. et al. Helicobacter pylori and unignorable extragastric diseases: mechanism and implications. Front. Microbiol. 13, 972777 (2022).
Boubrik, F. & Belmouden, A. El Kadmiri, N. Potential Non-invasive biomarkers of Helicobacter pylori-Associated gastric cancer. J. Gastrointest. Cancer. 53, 1113–1120 (2021).
Shiotani, A., Miyanishi, T., Uedo, N. & Iishi, H. Helicobacter pylori infection is associated with reduced Circulating Ghrelin levels independent of body mass index. Helicobacter 10, 373–378 (2005).
Fernandes das Neves, M., Batuca, J. R. & Delgado Alves, J. The role of high-density lipoprotein in the regulation of the immune response: implications for atherosclerosis and autoimmunity. Immunology 164, 231–241 (2021).
Navab, M., Anantharamaiah, G. M. & Fogelman, A. M. The role of high-density lipoprotein in inflammation. Trends Cardiovasc. Med. 15, 158–161 (2005).
Shimamoto, T. et al. The association of Helicobacter pylori infection with serum lipid profiles: an evaluation based on a combination of meta-analysis and a propensity score-based observational approach. PLoS One. 15, e0234433 (2020).
Sun, Y., Fu, D., Wang, Y. K., Liu, M. & Liu, X. D. Prevalence of Helicobacter pylori infection and its association with lipid profiles. Bratisl Lek Listy. 117, 521–524 (2016).
Upala, S., Sanguankeo, A., Saleem, S. A. & Jaruvongvanich, V. Effects of Helicobacter pylori eradication on insulin resistance and metabolic parameters: a systematic review and meta-analysis. Eur. J. Gastroenterol. Hepatol. 29, 153–159 (2017).
Yu, B. et al. The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) as a predictor of all-cause and cardiovascular mortality in US adults with diabetes or prediabetes: NHANES 1999–2018. BMC Med. 22, 317 (2024).
Du, Y. Z. et al. A cross-sectional analysis of the relationship between the non-high density to high density lipoprotein cholesterol ratio (NHHR) and kidney stone risk in American adults. Lipids Health Dis. 23, 158 (2024).
Tan, M. Y. et al. The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio with type 2 diabetes mellitus: recent findings from NHANES 2007–2018. Lipids Health Dis. 23, 151 (2024).
Qi, X. et al. The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and risk of depression among US adults: A cross-sectional NHANES study. J. Affect. Disord. 344, 451–457 (2024).
Wu, W. T. et al. Data mining in clinical big data: the frequently used databases, steps, and methodological models. Mil Med. Res. 8, 44 (2021).
Meier, H. C. S. et al. Helicobacter pylori seropositivity is associated with antinuclear antibodies in US adults, NHANES 1999–2000. Epidemiol. Infect. 148, e20 (2020).
Raja, V. et al. Non-HDL-cholesterol in dyslipidemia: review of the state-of-the-art literature and outlook. Atherosclerosis 383, 117312 (2023).
Yang, S. et al. Association between the non-HDL-cholesterol to HDL-cholesterol ratio and non-alcoholic fatty liver disease in Chinese children and adolescents: a large single-center cross-sectional study. Lipids Health Dis. 19, 242 (2020).
Sheng, G. et al. Utility of Non-High-Density lipoprotein cholesterol to High-Density lipoprotein cholesterol ratio in evaluating incident diabetes risk. Diabetes Metab. Syndr. Obes. 15, 1677–1686 (2022).
Wang, A. et al. Non-HDL-C/HDL-C ratio is associated with carotid plaque stability in general population: A cross-sectional study. Front. Neurol. 13, 875134 (2022).
Wu, R. & Gong, H. The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and chronic obstructive pulmonary disease: the mediating role of dietary inflammatory index. Front. Nutr. 11, 1427586 (2024).
Hou, K., Song, W., He, J. & Ma, Z. The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and prevalence of periodontitis among US adults: a cross-sectional NHANES study. Sci. Rep. 14, 5558 (2024).
Zhang, Y. & Zheng, X. Association of 28-day mortality with non-high-density lipoprotein cholesterol and the high-density lipoprotein cholesterol ratio (NHHR) in patients with sepsis: results of MIMIC-IV database analysis. Lipids Health Dis. 23, 255 (2024).
Upala, S., Jaruvongvanich, V., Riangwiwat, T., Jaruvongvanich, S. & Sanguankeo, A. Association between Helicobacter pylori infection and metabolic syndrome: a systematic review and meta-analysis. J. Dig. Dis. 17, 433–440 (2016).
Kucukazman, M. et al. The relationship between updated Sydney system score and LDL cholesterol levels in patients infected with Helicobacter pylori. Dig. Dis. Sci. 54, 604–607 (2008).
Xie, J., Wang, J., Zeng, R. & Xie, Y. Association between Helicobacter pylori infection and triglyceride levels: a nested cross-sectional study. Front. Endocrinol. 14, 1220347 (2023).
Wang, Z. et al. Eradication of Helicobacter pylori alleviates lipid metabolism deterioration: a large-cohort propensity score-matched analysis. Lipids Health Dis. 21, 34 (2022).
Iwai, N. et al. Helicobacter pylori eradication increases the serum high density lipoprotein cholesterol level in the infected patients with chronic gastritis: A single-center observational study. PLoS One. 14, e0221349 (2019).
Eslami, O., Shahraki, M., Shahraki, T. & Ansari, H. Association of Helicobacter pylori infection with metabolic parameters and dietary habits among medical undergraduate students in southeastern of Iran. J. Res. Med. Sci. 22, 12 (2017).
Ozturk, S. et al. Traditional and nontraditional lipid parameters in Helicobacter pylori infection. Biomark. Med. 18, 291–300 (2024).
Fang, Y., Fan, C., Li, Y. & Xie, H. The influence of Helicobacter pylori infection on acute coronary syndrome and lipid metabolism in the Chinese ethnicity. Front. Cell. Infect. Microbiol. 14, 1437425 (2024).
Makoveichuk, E., Vorrsjo, E., Olivecrona, T. & Olivecrona, G. TNF-alpha decreases lipoprotein lipase activity in 3T3-L1 adipocytes by up-regulation of angiopoietin-like protein 4. Biochim. Biophys. Acta Mol. Cell. Biol. Lipids. 1862, 533–540 (2017).
Sheu, W. H. H., Lee, W. J., Chang, R. L. & Chen, Y. T. Plasma tumor necrosis factor alpha levels and insulin sensitivity in hypertensive subjects. Clin. Exp. Hypertens. 22, 595–606 (2000).
Roper, J. et al. Leptin and Ghrelin in relation to Helicobacter pylori status in adult males. J. Clin. Endocrinol. Metab. 93, 2350–2357 (2008).
Yang, G. H. et al. Obesity associated with increased risk of gastric Helicobacter pylori infection in an elderly Chinese population. J. Am. Geriatr. Soc. 62, 190–192 (2014).
Shah, S. C. et al. Helicobacter pylori burden in the united States according to individual demographics and geography: A nationwide analysis of the veterans healthcare system. Clin. Gastroenterol. Hepatol. 22, 42–50 (2024). e26.
Seo, K. I. et al. Sex differences betweenHelicobacter pyloriinfection and cholesterol levels in an adult health checkup program. Helicobacter 25, e12704 (2020).
Zhang, L. et al. Helicobacter pylori infection selectively increases the risk for carotid atherosclerosis in young males. Atherosclerosis 291, 71–77 (2019).
